Cargando…
Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design
Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation and destruction of the lung air–blood barrier, leading to irreversible and substantial respiratory function damage. Patients with coronavirus disease 2019 (COVID-19) have been encountered with a high risk of ARDS,...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102084/ https://www.ncbi.nlm.nih.gov/pubmed/33977080 http://dx.doi.org/10.1016/j.apsb.2021.04.023 |